Cargando…

Differences in ICSI utilization rates among states with insurance mandates for ART coverage

BACKGROUND: Assisted reproductive technology (ART) insurance mandates promote more selective utilization of ART clinic resources including intracytoplasmic sperm injection (ICSI). Our objective was to examine whether ICSI utilization differs by state insurance mandates for ART coverage and assess if...

Descripción completa

Detalles Bibliográficos
Autores principales: Zagadailov, Pavel, Cho, Kyung S., Seifer, David B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630859/
https://www.ncbi.nlm.nih.gov/pubmed/34847941
http://dx.doi.org/10.1186/s12958-021-00856-4
_version_ 1784607443940016128
author Zagadailov, Pavel
Cho, Kyung S.
Seifer, David B.
author_facet Zagadailov, Pavel
Cho, Kyung S.
Seifer, David B.
author_sort Zagadailov, Pavel
collection PubMed
description BACKGROUND: Assisted reproductive technology (ART) insurance mandates promote more selective utilization of ART clinic resources including intracytoplasmic sperm injection (ICSI). Our objective was to examine whether ICSI utilization differs by state insurance mandates for ART coverage and assess if such a difference is associated with male factor, preimplantation genetic testing (PGT), and/or live birth rates. METHODS: In this retrospective analysis of the Centers for Disease Control (CDC) data from 2018, ART clinics in ART-mandated states (n = 8, AR, CT, HI, IL, MD, MA, NJ, RI) were compared individually to one another and with non-mandated states in aggregate (n = 42) for use of ICSI, male factor, PGT, and live birth rates. ANOVA was used to evaluate differences between ART-mandated states and non-mandated states. Individual ART-mandated states were compared using Welch t-tests. Statistical significance was determined by Bonferroni Correction. RESULTS: There were significant differences in ICSI rates (%, mean ± SD) between MA (53.3 ± 21.3) and HI (90.7 ± 19.6), p = 0.028; IL (86.5 ± 18.7) and MA, p = 0.002; IL and MD (57.2 ± 30.8), p = 0.039; IL and NJ (62.0 ± 26.8), p = 0.007; between non-mandated states in aggregate (79.9 ± 19.9) and MA, p = 0.006, and NJ (62.0 ± 26.8), p = 0.02. Male factor rates of HI (65.8 ± 16.0) were significantly greater compared to CT (18.8 ± 8.7), IL (26.0 ± 11.9), MA (26.9 ± 6.6), MD (29.3 ± 9.9), NJ (30.6 ± 17.9), and non-mandated states in aggregate (29.7 ± 13.7), all p < 0.0001. No significant differences were reported for use of PGT and/or live birth rates across all age groups regardless of mandate status. CONCLUSIONS: ICSI use varied significantly among ART-mandated states while demonstrating no differences in live birth rates. These data suggest that the prevalence of male factor and the presence of a state insurance mandate are not the only factors influencing ICSI use. It is suggested that other non-clinical factors may impact the rate of ICSI utilization in a given state. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12958-021-00856-4.
format Online
Article
Text
id pubmed-8630859
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86308592021-12-01 Differences in ICSI utilization rates among states with insurance mandates for ART coverage Zagadailov, Pavel Cho, Kyung S. Seifer, David B. Reprod Biol Endocrinol Research BACKGROUND: Assisted reproductive technology (ART) insurance mandates promote more selective utilization of ART clinic resources including intracytoplasmic sperm injection (ICSI). Our objective was to examine whether ICSI utilization differs by state insurance mandates for ART coverage and assess if such a difference is associated with male factor, preimplantation genetic testing (PGT), and/or live birth rates. METHODS: In this retrospective analysis of the Centers for Disease Control (CDC) data from 2018, ART clinics in ART-mandated states (n = 8, AR, CT, HI, IL, MD, MA, NJ, RI) were compared individually to one another and with non-mandated states in aggregate (n = 42) for use of ICSI, male factor, PGT, and live birth rates. ANOVA was used to evaluate differences between ART-mandated states and non-mandated states. Individual ART-mandated states were compared using Welch t-tests. Statistical significance was determined by Bonferroni Correction. RESULTS: There were significant differences in ICSI rates (%, mean ± SD) between MA (53.3 ± 21.3) and HI (90.7 ± 19.6), p = 0.028; IL (86.5 ± 18.7) and MA, p = 0.002; IL and MD (57.2 ± 30.8), p = 0.039; IL and NJ (62.0 ± 26.8), p = 0.007; between non-mandated states in aggregate (79.9 ± 19.9) and MA, p = 0.006, and NJ (62.0 ± 26.8), p = 0.02. Male factor rates of HI (65.8 ± 16.0) were significantly greater compared to CT (18.8 ± 8.7), IL (26.0 ± 11.9), MA (26.9 ± 6.6), MD (29.3 ± 9.9), NJ (30.6 ± 17.9), and non-mandated states in aggregate (29.7 ± 13.7), all p < 0.0001. No significant differences were reported for use of PGT and/or live birth rates across all age groups regardless of mandate status. CONCLUSIONS: ICSI use varied significantly among ART-mandated states while demonstrating no differences in live birth rates. These data suggest that the prevalence of male factor and the presence of a state insurance mandate are not the only factors influencing ICSI use. It is suggested that other non-clinical factors may impact the rate of ICSI utilization in a given state. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12958-021-00856-4. BioMed Central 2021-11-30 /pmc/articles/PMC8630859/ /pubmed/34847941 http://dx.doi.org/10.1186/s12958-021-00856-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zagadailov, Pavel
Cho, Kyung S.
Seifer, David B.
Differences in ICSI utilization rates among states with insurance mandates for ART coverage
title Differences in ICSI utilization rates among states with insurance mandates for ART coverage
title_full Differences in ICSI utilization rates among states with insurance mandates for ART coverage
title_fullStr Differences in ICSI utilization rates among states with insurance mandates for ART coverage
title_full_unstemmed Differences in ICSI utilization rates among states with insurance mandates for ART coverage
title_short Differences in ICSI utilization rates among states with insurance mandates for ART coverage
title_sort differences in icsi utilization rates among states with insurance mandates for art coverage
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630859/
https://www.ncbi.nlm.nih.gov/pubmed/34847941
http://dx.doi.org/10.1186/s12958-021-00856-4
work_keys_str_mv AT zagadailovpavel differencesinicsiutilizationratesamongstateswithinsurancemandatesforartcoverage
AT chokyungs differencesinicsiutilizationratesamongstateswithinsurancemandatesforartcoverage
AT seiferdavidb differencesinicsiutilizationratesamongstateswithinsurancemandatesforartcoverage